The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer
The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@ast
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@en
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@nl
type
label
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@ast
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@en
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@nl
prefLabel
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@ast
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@en
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@nl
P2093
P2860
P1476
The Targeted SMAC Mimetic SW I ...... motherapy in pancreatic cancer
@en
P2093
Jingxia Liu
Narendra V Sankpal
Pratibha S Binder
Robert H Mach
S Peter Goedegebuure
Suwanna Vangveravong
William G Hawkins
Yassar M Hashim
P2860
P2888
P356
10.1186/S13046-016-0470-4
P407
P50
P577
2017-01-17T00:00:00Z
P6179
1008943930